vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and Pure Storage, Inc. (PSTG). Click either name above to swap in a different company.

Pure Storage, Inc. is the larger business by last-quarter revenue ($964.5M vs $487.7M, roughly 2.0× CLOVER HEALTH INVESTMENTS, CORP.). Pure Storage, Inc. runs the higher net margin — 5.7% vs -10.1%, a 15.8% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (44.7% vs 16.0%). Pure Storage, Inc. produced more free cash flow last quarter ($52.6M vs $-69.0M). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (18.6% CAGR vs 10.5%).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

Pure Storage, Inc. is an American publicly traded technology company headquartered in Santa Clara, California, United States. It develops all-flash data storage hardware and software products. Pure Storage was founded in 2009 and developed its products in stealth mode until 2011. Afterwards, the company grew in revenues by about 50% per quarter and raised more than $470 million in venture capital funding, before going public in 2015. Initially, Pure Storage developed the software for storage ...

CLOV vs PSTG — Head-to-Head

Bigger by revenue
PSTG
PSTG
2.0× larger
PSTG
$964.5M
$487.7M
CLOV
Growing faster (revenue YoY)
CLOV
CLOV
+28.7% gap
CLOV
44.7%
16.0%
PSTG
Higher net margin
PSTG
PSTG
15.8% more per $
PSTG
5.7%
-10.1%
CLOV
More free cash flow
PSTG
PSTG
$121.6M more FCF
PSTG
$52.6M
$-69.0M
CLOV
Faster 2-yr revenue CAGR
CLOV
CLOV
Annualised
CLOV
18.6%
10.5%
PSTG

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
CLOV
CLOV
PSTG
PSTG
Revenue
$487.7M
$964.5M
Net Profit
$-49.3M
$54.8M
Gross Margin
72.3%
Operating Margin
-10.1%
5.6%
Net Margin
-10.1%
5.7%
Revenue YoY
44.7%
16.0%
Net Profit YoY
-123.2%
-13.9%
EPS (diluted)
$0.16

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
PSTG
PSTG
Q4 25
$487.7M
$964.5M
Q3 25
$496.6M
$861.0M
Q2 25
$477.6M
$778.5M
Q1 25
$462.3M
$879.8M
Q4 24
$337.0M
$831.1M
Q3 24
$331.0M
$763.8M
Q2 24
$356.3M
$693.5M
Q1 24
$346.9M
$789.8M
Net Profit
CLOV
CLOV
PSTG
PSTG
Q4 25
$-49.3M
$54.8M
Q3 25
$-24.4M
$47.1M
Q2 25
$-10.6M
$-14.0M
Q1 25
$-1.3M
$42.4M
Q4 24
$-22.1M
$63.6M
Q3 24
$-9.2M
$35.7M
Q2 24
$7.4M
$-35.0M
Q1 24
$-19.2M
$65.4M
Gross Margin
CLOV
CLOV
PSTG
PSTG
Q4 25
72.3%
Q3 25
70.2%
Q2 25
68.9%
Q1 25
67.5%
Q4 24
70.1%
Q3 24
24.5%
70.7%
Q2 24
30.3%
71.5%
Q1 24
23.6%
72.0%
Operating Margin
CLOV
CLOV
PSTG
PSTG
Q4 25
-10.1%
5.6%
Q3 25
-4.9%
0.6%
Q2 25
-2.2%
-4.0%
Q1 25
-0.3%
4.8%
Q4 24
-6.4%
7.2%
Q3 24
-2.7%
3.3%
Q2 24
2.0%
-6.0%
Q1 24
-6.5%
7.3%
Net Margin
CLOV
CLOV
PSTG
PSTG
Q4 25
-10.1%
5.7%
Q3 25
-4.9%
5.5%
Q2 25
-2.2%
-1.8%
Q1 25
-0.3%
4.8%
Q4 24
-6.6%
7.7%
Q3 24
-2.8%
4.7%
Q2 24
2.1%
-5.0%
Q1 24
-5.5%
8.3%
EPS (diluted)
CLOV
CLOV
PSTG
PSTG
Q4 25
$0.16
Q3 25
$0.14
Q2 25
$-0.04
Q1 25
$0.13
Q4 24
$0.19
Q3 24
$0.10
Q2 24
$-0.11
Q1 24
$0.22

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
PSTG
PSTG
Cash + ST InvestmentsLiquidity on hand
$78.3M
$852.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$308.7M
$1.4B
Total Assets
$541.0M
$4.2B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
PSTG
PSTG
Q4 25
$78.3M
$852.8M
Q3 25
$887.8M
Q2 25
$739.3M
Q1 25
$723.6M
Q4 24
$194.5M
$894.6M
Q3 24
$288.0M
$965.0M
Q2 24
$254.8M
$900.6M
Q1 24
$208.3M
$702.5M
Stockholders' Equity
CLOV
CLOV
PSTG
PSTG
Q4 25
$308.7M
$1.4B
Q3 25
$340.9M
$1.3B
Q2 25
$344.2M
$1.2B
Q1 25
$336.1M
$1.3B
Q4 24
$341.1M
$1.4B
Q3 24
$342.2M
$1.5B
Q2 24
$324.9M
$1.4B
Q1 24
$292.5M
$1.3B
Total Assets
CLOV
CLOV
PSTG
PSTG
Q4 25
$541.0M
$4.2B
Q3 25
$559.7M
$4.0B
Q2 25
$575.0M
$3.8B
Q1 25
$583.7M
$4.0B
Q4 24
$580.7M
$3.9B
Q3 24
$653.0M
$3.8B
Q2 24
$674.2M
$3.6B
Q1 24
$671.8M
$3.7B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLOV
CLOV
PSTG
PSTG
Operating Cash FlowLast quarter
$-66.9M
$116.0M
Free Cash FlowOCF − Capex
$-69.0M
$52.6M
FCF MarginFCF / Revenue
-14.1%
5.5%
Capex IntensityCapex / Revenue
0.4%
6.6%
Cash ConversionOCF / Net Profit
2.12×
TTM Free Cash FlowTrailing 4 quarters
$-69.2M
$566.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLOV
CLOV
PSTG
PSTG
Q4 25
$-66.9M
$116.0M
Q3 25
$12.1M
$212.2M
Q2 25
$5.4M
$283.9M
Q1 25
$-16.3M
$208.5M
Q4 24
$34.8M
$97.0M
Q3 24
$50.0M
$226.6M
Q2 24
$44.8M
$221.5M
Q1 24
$25.9M
$244.4M
Free Cash Flow
CLOV
CLOV
PSTG
PSTG
Q4 25
$-69.0M
$52.6M
Q3 25
$11.4M
$150.1M
Q2 25
$4.8M
$211.6M
Q1 25
$-16.5M
$152.4M
Q4 24
$33.3M
$35.2M
Q3 24
$49.6M
$166.6M
Q2 24
$44.4M
$172.7M
Q1 24
$25.5M
$200.9M
FCF Margin
CLOV
CLOV
PSTG
PSTG
Q4 25
-14.1%
5.5%
Q3 25
2.3%
17.4%
Q2 25
1.0%
27.2%
Q1 25
-3.6%
17.3%
Q4 24
9.9%
4.2%
Q3 24
15.0%
21.8%
Q2 24
12.5%
24.9%
Q1 24
7.3%
25.4%
Capex Intensity
CLOV
CLOV
PSTG
PSTG
Q4 25
0.4%
6.6%
Q3 25
0.1%
7.2%
Q2 25
0.1%
9.3%
Q1 25
0.0%
6.4%
Q4 24
0.5%
7.4%
Q3 24
0.1%
7.9%
Q2 24
0.1%
7.0%
Q1 24
0.1%
5.5%
Cash Conversion
CLOV
CLOV
PSTG
PSTG
Q4 25
2.12×
Q3 25
4.50×
Q2 25
Q1 25
4.91×
Q4 24
1.52×
Q3 24
6.35×
Q2 24
6.04×
Q1 24
3.74×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLOV
CLOV

Segment breakdown not available.

PSTG
PSTG

US$683.2M71%
Non Us$281.3M29%

Related Comparisons